Evidence map›Paper›PMID 35118351›Full record

ArticleEuropean journal of midwifery2022

Hesitancy towards a COVID-19 vaccine among midwives in Turkey during the COVID-19 pandemic: A cross-sectional web-based survey.

Leyla Kaya, Yasemin Aydın-Kartal

Open access · goldAbstract read
In one paragraph

Article in European journal of midwifery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Leyla KayaZeynep Kamil Women and Children's Diseases Training and Research Hospital, Gynecology Clinic, Istanbul, Turkey.
Yasemin Aydın-KartalDepartment of Midwifery, Faculty of Health Sciences, University of Health Sciences, Istanbul, Turkey.
Birthingway College of Midwifery · USZeynep Kamil Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOne of the most significant barriers to social immunization, which is critical in combating the COVID-19 pandemic, is vaccine hesitancy or rejection. The purpose of this study was to determine the acceptance, hesitancy and barriers to COVID-19 vaccines among midwives in Turkey.

methodsA total of 806 midwives participated in the cross-sectional study, which was conducted online from November 2020 to January 2021. The data were collected by using an Introductory Information Form, Anti-Vaccination Scale - Short Form, and Attitudes to the COVID-19 Vaccine Scale.

resultsIn all, 17.2% of the midwives in the study had a history of COVID-19 infection, which was confirmed by a PCR test; 69% were exposed to COVID-19 patients; 36.8% had a person diagnosed with COVID-19 with PCR in their family; and 18.1% had a relative die due to COVID-19. In the study, 16.8% of midwives considered getting the COVID-19 vaccine, while the majority (48.8%) stated they would get the vaccine once vaccine safety was established, while 10.5% stated that they did not wish to receive the vaccine. Insufficient phase studies of COVID-19 vaccine studies (75.6%) and insufficient control due to imported COVID-19 vaccines developed (48.1%) were among the most important determinants of COVID-19 vaccine reluctance.

conclusionsThe potential acceptance rate of COVID-19 vaccines by the study midwives was found to be low. The knowledge, confidence and attitude of midwives toward vaccines are important determinants of patients' vaccine acceptance and recommendation.

Indexed as

COVID-19midwivesvaccine acceptancevaccine hesitancy

Identifiers

PMID35118351
PMCPMC8788385
OpenAlexW4206987595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.